These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21044639)

  • 61. S 38093, a histamine H
    Guilloux JP; Samuels BA; Mendez-David I; Hu A; Levinstein M; Faye C; Mekiri M; Mocaer E; Gardier AM; Hen R; Sors A; David DJ
    Sci Rep; 2017 Feb; 7():42946. PubMed ID: 28218311
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Histamine H3 receptor antagonists ameliorate attention deficit/hyperactivity disorder-like behavioral changes caused by neonatal habenula lesion.
    Kim YJ; Goto Y; Lee YA
    Behav Pharmacol; 2018 Feb; 29(1):71-78. PubMed ID: 28863002
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Computational analysis of novel drugs designed for use as acetylcholinesterase inhibitors and histamine H3 receptor antagonists for Alzheimer's disease by docking, scoring and de novo evolution.
    Chen PY; Tsai CT; Ou CY; Hsu WT; Jhuo MD; Wu CH; Shih TC; Cheng TH; Chung JG
    Mol Med Rep; 2012 Apr; 5(4):1043-8. PubMed ID: 22267207
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease.
    Jensen MM; Arvaniti M; Mikkelsen JD; Michalski D; Pinborg LH; Härtig W; Thomsen MS
    Neurobiol Aging; 2015 Apr; 36(4):1629-1638. PubMed ID: 25680266
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits.
    Savage DD; Rosenberg MJ; Wolff CR; Akers KG; El-Emawy A; Staples MC; Varaschin RK; Wright CA; Seidel JL; Caldwell KK; Hamilton DA
    Alcohol Clin Exp Res; 2010 Oct; 34(10):1793-802. PubMed ID: 20626729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. GSK3beta signalling: casting a wide net in Alzheimer's disease.
    Bhat RV; Budd SL
    Neurosignals; 2002; 11(5):251-61. PubMed ID: 12566926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonist.
    Hudzik TJ; Basso A; Boyce-Rustay JM; Bracken W; Browman KE; Drescher K; Esbenshade TA; Loberg LI; Lynch JJ; Brioni JD
    Psychopharmacology (Berl); 2013 Jul; 228(2):187-97. PubMed ID: 23455597
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Histamine H3 receptor antagonists go to clinics.
    Sander K; Kottke T; Stark H
    Biol Pharm Bull; 2008 Dec; 31(12):2163-81. PubMed ID: 19043195
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro mitochondrial failure and oxidative stress mimic biochemical features of Alzheimer disease.
    Selvatici R; Marani L; Marino S; Siniscalchi A
    Neurochem Int; 2013 Aug; 63(2):112-20. PubMed ID: 23722080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice.
    Cuadrado-Tejedor M; Garcia-Barroso C; Sánchez-Arias JA; Rabal O; Pérez-González M; Mederos S; Ugarte A; Franco R; Segura V; Perea G; Oyarzabal J; Garcia-Osta A
    Neuropsychopharmacology; 2017 Jan; 42(2):524-539. PubMed ID: 27550730
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Histamine H
    Falkenstein M; Reiner-Link D; Zivkovic A; Gering I; Willbold D; Stark H
    Bioorg Med Chem; 2021 Nov; 50():116462. PubMed ID: 34695709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bioluminescence Resonance Energy Transfer Based G Protein-Activation Assay to Probe Duration of Antagonism at the Histamine H
    Mocking TAM; Buzink MCML; Leurs R; Vischer HF
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366084
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The dual-active histamine H3 receptor antagonist and acetylcholine esterase inhibitor E100 ameliorates stereotyped repetitive behavior and neuroinflammmation in sodium valproate induced autism in mice.
    Eissa N; Azimullah S; Jayaprakash P; Jayaraj RL; Reiner D; Ojha SK; Beiram R; Stark H; Łażewska D; Kieć-Kononowicz K; Sadek B
    Chem Biol Interact; 2019 Oct; 312():108775. PubMed ID: 31369746
    [TBL] [Abstract][Full Text] [Related]  

  • 74. SAR110894, a potent histamine H3-receptor antagonist, displays disease-modifying activity in a transgenic mouse model of tauopathy.
    Delay-Goyet P; Blanchard V; Schussler N; Lopez-Grancha M; Ménager J; Mary V; Sultan E; Buzy A; Guillemot JC; Stemmelin J; Bertrand P; Rooney T; Pradier L; Barnéoud P
    Alzheimers Dement (N Y); 2016 Nov; 2(4):267-280. PubMed ID: 29067314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reduced pCREB in Alzheimer's disease prefrontal cortex is reflected in peripheral blood mononuclear cells.
    Bartolotti N; Bennett DA; Lazarov O
    Mol Psychiatry; 2016 Sep; 21(9):1158-66. PubMed ID: 27480489
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases.
    Raddatz R; Tao M; Hudkins RL
    Curr Top Med Chem; 2010; 10(2):153-69. PubMed ID: 20166960
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crystal structure of GSK3β in complex with the flavonoid, morin.
    Kim K; Cha JS; Kim JS; Ahn J; Ha NC; Cho HS
    Biochem Biophys Res Commun; 2018 Oct; 504(2):519-524. PubMed ID: 30197003
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multifunctional Ligands with Glycogen Synthase Kinase 3 Inhibitory Activity as a New Direction in Drug Research for Alzheimer's Disease.
    Jankowska A; Satała G; Bojarski AJ; Pawłowski M; Chłoń-Rzepa G
    Curr Med Chem; 2021; 28(9):1731-1745. PubMed ID: 32338201
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease.
    Potter A; Corwin J; Lang J; Piasecki M; Lenox R; Newhouse PA
    Psychopharmacology (Berl); 1999 Mar; 142(4):334-42. PubMed ID: 10229057
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives.
    Bhowmik M; Khanam R; Vohora D
    Br J Pharmacol; 2012 Dec; 167(7):1398-414. PubMed ID: 22758607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.